According to the report published by Visiongain, the Artificial Pancreas Device System (APDS) market is estimated to be valued at USD 187.3 million in 2020 and is expected grow at a CAGR of 20.2% during the forecast period 2020-2030. The artificial pancreas (AP) is an internally carried medical device that mimics the biological pancreas ‘ endocrine role by controlling blood glucose (BGL) levels. It infuses insulin and potentially glucagon to regulate BGL to type 1 diabetic disease in a more streamlined fashion according to an suitable monitoring law. Offering movement, efficiency since using digital communication methods and sophisticated software algorithms it will automatically regulate and control the amount of glucose. In addition to preventing hyperglycemia (increase in glucose concentrations), which in the course of moment contributes to the growth of complications such as: heart, kidney, nose, muscle and foot harm, cardiovascular diseases and Alzheimer’s, while hypoglycemia (fall in glucose concentrations) can be distressing and lead to coma or mortality.
An artificial pancreas, according to the FDA, is a medical device that connects a glucose monitor to an insulin infusion pump where the pump automatically decreases and raises subcutaneous insulin delivery using a command algorithm according to defined subcutaneous glucose concentrations. Because control algorithms can vary significantly, there are a variety of artificial pancreas device systems currently under development. These systems span a wide range of designs from low glucose suspend (LGS) device systems to the more complex bihormonal control-to-target systems.
FDA has described 3 main categories of artificial pancreas device systems:
1. Threshold Suspend Device System With novice suspension cell devices, also known as small glucose suspension devices, insulin delivery is stopped for a fixed moment when 2 concentrations of glucose are below a defined low level of hypoglycemia
2. Control-to-Range System With these technologies, the person establishes his or her own insulin dose within a defined scope, but if glucose concentrations achieve outside that scope (greater or smaller), the artificial pancreas apparatus scheme carries over. Patients using this form of scheme still require blood glucose concentrations to be checked and insulin given as required.
3. Control-to-target scheme The device seeks to keep glucose concentrations close to a goal point, such as 100 mg / dL, with this sort of scheme. Control-to-target devices are automatic and involve no customer involvement except for the ongoing glucose surveillance device calibration. Several apparatus subtypes such as those delivering insulin-only, bi-hormonal devices, and hybrid systems are being created.
During the forecast period, Asia Pacific is anticipated to show the highest development. Due to diet, dna alteration, urbanization and aging, this region has the largest amount of people with diabetes. It is anticipated that increasing diabetes incidences will sustain market growth over the forecast period. Asian nations add more than 60 times to the world’s diabetic population, contributing to the development of the region’s APDS industry, according to an essay released by NCBI. In addition, industry participants are anticipated to increase the industry by extending their facilities across the region. Johnson & Johnson, for example, introduced its Asia Pacific development hub in 2014 to deliver technological progress and improve treatment quality. Such factors are driving the growth of the market.
Growing Prevalence of Diabetes
Diabetes is a chronic disease that is life-threatening without any specific remedy. It is primarily due to the failure of the body to generate or use the hormone insulin efficiently. Diabetes is one of the 21st century’s biggest global health hazards. This disease is experienced by more and more individuals every year, which can lead to life-changing problems. According to the International Diabetes Federation (IDF), there were roughly 46 million individuals with diabetes in North America in 2017, which is anticipated to increase to 62 million in 2045. The rise in the incidence of disease during the forecast period is around 35 percent fold.
Why you should buy Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis by Type (Control – to – Range (CTR) System, Threshold Suspended Device System, and Control – to – Target (CTT) System), by Treatment Type (Bi-hormonal, Insulin Only, and Hybrid) and Geography, with Profiles of Leading Companies.
What is the future of the Artificial Pancreas Device System (APDS) market?
Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information
– View Artificial Pancreas Device System (APDS) market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Artificial Pancreas Device System (APDS) revenue forecast
– Artificial Pancreas Device System (APDS) connections forecast
– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Artificial Pancreas Device System (APDS) market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Artificial Pancreas Device System (APDS) sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Artificial Pancreas Device System (APDS) industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Artificial Pancreas Device System (APDS) submarkets with individual forecasts and analysis from 2020-2030.
– Type submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– submarket forecast 2020-2030
– Learn about the market prospects for the leading Artificial Pancreas Device System (APDS) market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Artificial Pancreas Device System (APDS) revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Type Revenue Forecast 2020-2030
– CTR (Control to Range) Systems Market Forecast, 2020-2030
– CTT (Control to Target) Systems Market Forecast, 2020-2030
– Other Type Market Forecast, 2020-2030
– End-Use Revenue Forecast 2020-2030
– Hospital Market Forecast, 2020-2030
– Medical Centers Market Forecast, 2020-2030
– Other End-Use Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Artificial Pancreas Device System (APDS) markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Artificial Pancreas Device System (APDS) companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– US Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Canada Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Mexico Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– North America Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– North America Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– North America Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– China Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Japan Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– India Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Australia Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Rest of Asia Pacific Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– Asia Pacific Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Germany Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– UK Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– France Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Italy Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Spain Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Rest of Europe Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– European Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) by Type revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) by End-Use revenue forecast 2020-2030
– Rest of World Artificial Pancreas Device System (APDS) by revenue forecast 2020-2030
– Explore the factors affecting Artificial Pancreas Device System (APDS) product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Artificial Pancreas Device System (APDS) industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Artificial Pancreas Device System (APDS) companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Artificial Pancreas Device System (APDS) Market
Beta Bionics
TypeZero Technologies, LLC
Pancreum, Inc.
Tandem Diabetes Care, Inc.
Johnson & Johnson
Bigfoot Biomedical
Medtronic
DreaMed Diabetes Ltd
Inreda Diabetic BV
Insulet Corporation
Medtrum Technologies Inc.
Discover Information found nowhere else in this independent assessment of the Artificial Pancreas Device System (APDS) market
The Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Pancreas Device System (APDS) sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Artificial Pancreas Device System (APDS) market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Artificial Pancreas Device System (APDS) sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Artificial Pancreas Device System (APDS) Market Forecast 2020-2030: Forecasts and Analysis By Type, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Pancreas Device System (APDS) sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Artificial Pancreas Device System (APDS) Market Definition
1.2 Global Artificial Pancreas Device System (APDS) Market Overview
1.3 Global Artificial Pancreas Device System (APDS) Market Segmentation
1.4 Research Scope of Artificial Pancreas Device System (APDS) in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Artificial Pancreas Device System (APDS) Systems Market
2.1 Market Definition
2.2 Industry Structure
2.3 Industry Outlook
2.4 Current Status & Trends
2.4.1 medical science and major movements have been increasing quickly in recent centuries
2.5 Product Penetration & growth prospect Analysis
2.5.1 Advanced manufacturing process innovation
3. Global Artificial Pancreas Device System (APDS) Market Analysis
3.1 PEST Analysis of the Artificial Pancreas Device System (APDS) Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Artificial Pancreas Device System (APDS) Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Artificial Pancreas Device System (APDS): Global Market Analysis by Segments
4.1 Global Artificial Pancreas Device System (APDS) Market Forecast, by Type 2020-2030
4.1.1 Type Overview
4.1.2 CTR (Control to Range) Systems Market Forecast, 2020-2030
4.1.3 CTT (Control to Target) Systems Market Forecast, 2020-2030
4.1.4 Other Type Market Forecast, 2020-2030
4.2 Global Artificial Pancreas Device System (APDS) Market Forecast, by End-Use 2020-2030
4.2.1 End-Use Overview
4.2.2 Hospital Market Forecast, 2020-2030
4.2.3 Medical Centers Market Forecast, 2020-2030
4.2.4 Other End-Use Market Forecast, 2020-2030
5. Leading Regions in Artificial Pancreas Device System (APDS) Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Artificial Pancreas Device System (APDS) Market Forecast, 2020-2030
5.2.1 North America Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
5.2.2 North America Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030
5.2.3 North America Artificial Pancreas Device System (APDS) Submarket, By Forecast 2020-2030
5.2.4 North America Artificial Pancreas Device System (APDS) Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.2.4.2 Canada Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.2.4.3 Mexico Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3 Europe Artificial Pancreas Device System (APDS) Market Forecast, 2020-2030
5.3.1 Europe Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
5.3.2 Europe Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030
5.3.3 Europe Artificial Pancreas Device System (APDS) Submarket, By Forecast 2020-2030
5.3.4 Europe Artificial Pancreas Device System (APDS) Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3.4.2 Germany Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3.4.3 France Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3.4.4 Italy Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3.4.5 Spain Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3.4.6 The Netherlands Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4 Asia-Pacific Artificial Pancreas Device System (APDS) Market Forecast, 2020-2030
5.4.1 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
5.4.2 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030
5.4.3 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By Forecast 2020-2030
5.4.4 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By Country Forecast 2020-2030
5.4.4.1 China Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4.4.2 India Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4.4.3 Japan Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4.4.4 Korea Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4.4.5 Indonesia Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4.4.6 Australia Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Artificial Pancreas Device System (APDS) Market, Forecast 2020-2030
5.5 Rest of World Artificial Pancreas Device System (APDS) Market Forecast, 2020-2030
5.5.1 Rest of World Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
5.5.2 Rest of World Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030
5.5.3 Rest of World Artificial Pancreas Device System (APDS) Submarket, By Forecast 2020-2030
6. Leading Companies in The Artificial Pancreas Device System (APDS) Market
6.1 Beta Bionics
6.1.1 Beta Bionics Overview
6.1.2 Analysis of Beta Bionics Products and Services
6.1.3 Beta Bionics Primary Market Competitors 2019
6.1.4 Beta Bionics Key Developments
6.2 TypeZero Technologies, LLC
6.2.1 TypeZero Technologies, LLC Company Overview
6.2.2 Analysis of TypeZero Technologies, LLC Products and Services
6.2.3 TypeZero Technologies, LLC Primary Market Competitors 2019
6.2.4 TypeZero Technologies, LLC Key Developments
6.3 Pancreum, Inc.
6.3.1 Pancreum, Inc. Company Overview
6.3.2 Analysis of Pancreum, Inc. Products and Services
6.3.3 Pancreum, Inc. Primary Market Competitors 2019
6.3.4 Pancreum, Inc. Key Developments
6.4 Tandem Diabetes Care, Inc.
6.4.1 Tandem Diabetes Care, Inc. Company Overview
6.4.2 Analysis of Tandem Diabetes Care, Inc. Products and Services
6.4.3 Tandem Diabetes Care, Inc. Primary Market Competitors 2019
6.4.4 Tandem Diabetes Care, Inc. Key Developments
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Overview
6.5.2 Analysis of Johnson & Johnson Products and Services
6.5.3 Johnson & Johnson Primary Market Competitors 2019
6.5.4 Johnson & Johnson Key Developments
6.6 Bigfoot Biomedical
6.6.1 Bigfoot Biomedical Company Overview
6.6.2 Analysis of Bigfoot Biomedical Products and Services
6.6.3 Bigfoot Biomedical Primary Market Competitors 2019
6.6.4 Bigfoot Biomedical Key Developments
6.7 Medtronic
6.7.1 Medtronic Company Overview
6.7.2 Analysis of Medtronic Products and Services
6.7.3 Medtronic Primary Market Competitors 2019
6.7.4 Medtronic Key Developments
6.8 DreaMed Diabetes Ltd
6.8.1 DreaMed Diabetes Ltd Company Overview
6.8.2 Analysis of DreaMed Diabetes Ltd Products and Services
6.8.3 DreaMed Diabetes Ltd Primary Market Competitors 2019
6.8.4 DreaMed Diabetes Ltd Key Developments
6.9 Inreda Diabetic BV
6.9.1 Inreda Diabetic BV Company Overview
6.9.2 Analysis of Inreda Diabetic BV Products and Services
6.9.3 Inreda Diabetic BV Primary Market Competitors 2019
6.9.4 Inreda Diabetic BV Key Developments
6.10 Insulet Corporation
6.10.1 Insulet Corporation Company Overview
6.10.2 Analysis of Insulet Corporation Products and Services
6.10.3 Insulet Corporation Primary Market Competitors 2019
6.10.4 Insulet Corporation Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Artificial Pancreas Device System (APDS) Market Segmentation
Figure 2.1 Artificial Pancreas Device System (APDS) Value Chain Analysis
Figure 3.1 Artificial Pancreas Device System (APDS) Supply-Demand Analysis
Figure 4.1 Global Artificial Pancreas Device System (APDS) Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Artificial Pancreas Device System (APDS) Market Forecast 2020-2030
Figure 4.3 Global Artificial Pancreas Device System (APDS) Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Artificial Pancreas Device System (APDS) Market By Type Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Artificial Pancreas Device System (APDS) by Submarket By Type Forecast 2020-2030 ($ million)
Figure 4.20 Global Artificial Pancreas Device System (APDS) Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Artificial Pancreas Device System (APDS) Market, By End-Use Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Artificial Pancreas Device System (APDS) Market, By System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Artificial Pancreas Device System (APDS) Market, By Type Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Artificial Pancreas Device System (APDS) Market, By End-Use Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Artificial Pancreas Device System (APDS) Market, by 2020-2030
Figure 5.3 Leading Country/Regional Artificial Pancreas Device System (APDS) Market Share, by 2020
Figure 5.4 Leading Country/Regional Artificial Pancreas Device System (APDS) Market Share, by 2025
Figure 5.5 Leading Country/Regional Artificial Pancreas Device System (APDS) Market Share, by 2030
Figure 5.6 Europe Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Artificial Pancreas Device System (APDS) Market, by Forecast 2020-2030
Figure 5.8 Europe Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
Figure 5.9 Europe Artificial Pancreas Device System (APDS) Submarket , By End-Use Forecast 2020-2030
Figure 5.10 Europe Artificial Pancreas Device System (APDS) Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Artificial Pancreas Device System (APDS) Submarket , By 2020-2030 ($billion, AGR%)
Figure 5.10 North America Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Artificial Pancreas Device System (APDS) Market, by Forecast 2020-2030
Figure 5.12 North America Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
Figure 5.13 North America Artificial Pancreas Device System (APDS) Submarket , By End-Use Forecast 2020-2030
Figure 5.14 North America Artificial Pancreas Device System (APDS) Submarket , By Forecast 2020-2030
Figure 5.13 North America Artificial Pancreas Device System (APDS) Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Artificial Pancreas Device System (APDS) Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
Figure 5.17 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket , By Forecast 2020-2030
Figure 5.18 Rest of World Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Artificial Pancreas Device System (APDS) Market, by Forecast 2020-2030
Figure 5.20 Rest of World Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030
Figure 5.21 Rest of World Artificial Pancreas Device System (APDS) Submarket , By End-Use Forecast 2020-2030
Figure 5.21 Rest of World Artificial Pancreas Device System (APDS) Submarket , By Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 TypeZero Technologies, LLC Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Pancreum, Inc. Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Tandem Diabetes Care, Inc. Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Tandem Diabetes Care, Inc. Revenue % Share, by Segment, 2019
Figure 6.8 Tandem Diabetes Care, Inc. Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Tandem Diabetes Care, Inc. Revenue % Share, by Business Segment, 2019
Figure 6.10 Johnson & Johnson Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Bigfoot Biomedical Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 Medtronic Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 Medtronic Revenue % Share, by Regional Segment, 2019
Figure 6.14 DreaMed Diabetes Ltd Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 DreaMed Diabetes Ltd Revenue % Share, by Regional Segment, 2019
Figure 6.16 DreaMed Diabetes Ltd Revenue % Share, by Business Segment, 2019
Figure 6.17 Inreda Diabetic BV Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Insulet Corporation Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Insulet Corporation Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Insulet Corporation Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Artificial Pancreas Device System (APDS) Submarket, By Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Artificial Pancreas Device System (APDS) Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Artificial Pancreas Device System (APDS) Market Submarket, By Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Artificial Pancreas Device System (APDS) Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Artificial Pancreas Device System (APDS) Market Submarket, By Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Artificial Pancreas Device System (APDS) Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Artificial Pancreas Device System (APDS) Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 TypeZero Technologies, LLC Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 TypeZero Technologies, LLC Products and Services (Product/Service, Segment)
Table 6.8 TypeZero Technologies, LLC Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 TypeZero Technologies, LLC Total Company Recent Development 2015-2019
Table 6.10 Pancreum, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Pancreum, Inc. Products and Services (Product/Service, Segment)
Table 6.12 Pancreum, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Pancreum, Inc. Total Company Recent Development 2015-2019
Table 6.14 Tandem Diabetes Care, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Tandem Diabetes Care, Inc. Products and Services (Product/Service, Segment)
Table 6.16 Tandem Diabetes Care, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Tandem Diabetes Care, Inc. Total Company Recent Development 2015-2019
Table 6.18 Johnson & Johnson Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Johnson & Johnson Products and Services (Product/Service, Segment)
Table 6.20 Johnson & Johnson Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Johnson & Johnson Total Company Recent Development 2015-2019
Table 6.22 Bigfoot Biomedical Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Bigfoot Biomedical Products and Services (Product/Service, Segment)
Table 6.24 Bigfoot Biomedical Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Bigfoot Biomedical Total Company Recent Development 2015-2019
Table 6.26 Medtronic Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 Medtronic Products and Services (Product/Service, Segment)
Table 6.28 Medtronic Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 Medtronic Total Company Recent Development 2015-2019
Table 6.30 DreaMed Diabetes Ltd Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 DreaMed Diabetes Ltd Products and Services (Product/Service, Segment)
Table 6.32 DreaMed Diabetes Ltd Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 DreaMed Diabetes Ltd Total Company Recent Development 2015-2019
Table 6.34 Inreda Diabetic BV Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Inreda Diabetic BV Products and Services (Product/Service, Segment)
Table 6.36 Inreda Diabetic BV Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Inreda Diabetic BV Total Company Recent Development 2015-2019
Table 6.38 Insulet Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Insulet Corporation Products and Services (Product/Service, Segment)
Table 6.40 Insulet Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Insulet Corporation Total Company Recent Development 2015-2019
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
